BioClinica
- Company typePrivate
- Founded1998
- HeadquartersNewtown, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingSoftware
BioClinica firmographics
Firmographics- Name
- BioClinica
- Website
- https://bioclinica.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Ownership category
- akta.pro rank
Where BioClinica is headquartered
LocationHeadquarters
- HQ city
- Newtown
- HQ country
- United States
- HQ region
- North America
Markets served
BioClinica business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
BioClinica product offering
Product offeringCore offering
BioClinica provides integrated, technology-enhanced clinical trial management solutions for the pharmaceutical and biotechnology industries. The company is positioned as a key technology and services provider in the pharmacovigilance market, supporting drug safety and adverse event monitoring across clinical development programs.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmacovigilance Solutions
Companies that use BioClinica
Customer profileIdeal customer profiles1 record
BioClinica technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BioClinica partnerships and signals
Strategic signalScale indicators1 record
Expansion highlights4 records
BioClinica competitors and assessment
Company assessmentDirect peers
- Veeva Systems: Veeva's Vault Clinical and Vault Safety suites compete directly with BioClinica's EDC, CTMS, and pharmacovigilance technology offerings. Veeva is a key benchmark for cloud-native clinical and safety platforms targeting the same sponsor buyers.
- ArisGlobal: ArisGlobal provides LifeSphere Safety and other pharmacovigilance and regulatory platforms, and is explicitly named alongside BioClinica in the Germany PV market. It is a direct competitor in the same PV technology and services category.
- Clario: Clario was formed from the combination of BioClinica and ERT and offers clinical trial endpoint technology, imaging, eCOA, and PV services. It is the most directly comparable peer because BioClinica's clinical trial management and imaging core lab capabilities map one-to-one onto Clario's portfolio today.
- Signant Health: Signant Health specializes in eCOA, eConsent, patient engagement, and clinical trial technology, overlapping BioClinica's technology-enabled trial management solutions (notably via Blueprint Clinical heritage). It is a focused technology peer rather than a broad CRO.
- Medidata (Dassault Systèmes): Medidata provides the Rave EDC, eCOA, imaging, and RTSM platform that powers a large share of industry clinical trials. It is the principal technology-side competitor to BioClinica's clinical trial management solutions and is increasingly bundled with CRO services.
Broad incumbents
- ICON plc: ICON is a top-3 global CRO with deep clinical operations and a technology platform (including Firecrest and ICONIK). It competes with BioClinica for full-service and embedded technology-enabled trial management engagements across pharma and biotech.
- Parexel International: Parexel is a global CRO with biopharmaceutical services, clinical trial technology, and pharmacovigilance capabilities. It competes with BioClinica for both functional service and full-service clinical trial engagements.
- IQVIA: IQVIA is the largest global CRO with embedded technology (E360, Orchestrated Patient Engagement) and a sizable pharmacovigilance practice. It overlaps BioClinica's clinical operations, technology-enabled trial management, and PV offerings, but at substantially greater scale and broader service breadth.
- Fortrea (formerly Labcorp Drug Development): Fortrea provides clinical development and safety/PV services carved out from Labcorp. It is a direct competitor to BioClinica across early- and late-phase clinical operations and post-market pharmacovigilance.
- Oracle Health Sciences (Clinical One / Siebel): Oracle offers Clinical One RTSM/EDC, eClinical technology, and safety/PV solutions that overlap BioClinica's clinical trial management and pharmacovigilance offerings, typically sold into larger sponsor accounts with embedded Oracle footprints.
Market position
Weaknesses5 records
Competitive moat4 records
Key highlights5 records
Customer concentration
BioClinica social profiles
Digital presenceBioClinica financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioClinica leadership team
Management profileNumber of profiles
Profiles2 records
BioClinica funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioClinica M&A and investment
M&A and investmentM&A11 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioClinica
What does BioClinica do?
BioClinica provides integrated, technology-enhanced clinical trial management solutions for the pharmaceutical and biotechnology industries. The company is positioned as a key technology and services provider in the pharmacovigilance market, supporting drug safety and adverse event monitoring across clinical development programs.
When was BioClinica founded?
BioClinica was founded in 1998. It employs 1,001 to 5,000 people.
Where is BioClinica based?
BioClinica is headquartered in Newtown, United States, in the North America region.
Who are BioClinica's main competitors?
Direct peers on record are Veeva Systems, ArisGlobal, Clario, Signant Health and Medidata (Dassault Systèmes). Broad incumbents are ICON plc, Parexel International, IQVIA, Fortrea (formerly Labcorp Drug Development) and Oracle Health Sciences (Clinical One / Siebel).
Does BioClinica have an API?
No public API is recorded for BioClinica.